DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,058 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,891,963 | +3.1% | 23,582 | +3.1% | 0.03% | -15.4% |
Q1 2024 | $5,714,592 | -30.6% | 22,884 | -35.7% | 0.04% | -40.0% |
Q4 2023 | $8,237,092 | +129.8% | 35,606 | +138.9% | 0.06% | +54.8% |
Q3 2023 | $3,584,440 | -74.6% | 14,902 | -74.7% | 0.04% | -77.7% |
Q2 2023 | $14,123,040 | +356.0% | 58,846 | +378.9% | 0.19% | +337.2% |
Q1 2023 | $3,097,320 | -87.6% | 12,289 | -86.9% | 0.04% | -89.0% |
Q4 2022 | $24,949,480 | +14.4% | 94,000 | -44.3% | 0.39% | +57.9% |
Q3 2022 | $21,812,791 | -10.6% | 168,742 | +75.3% | 0.25% | -48.9% |
Q2 2022 | $24,409,000 | -4.6% | 96,282 | +10.4% | 0.48% | +56.8% |
Q1 2022 | $25,582,000 | +688.6% | 87,210 | +784.5% | 0.31% | +1183.3% |
Q4 2021 | $3,244,000 | +744.8% | 9,860 | +681.9% | 0.02% | +700.0% |
Q3 2021 | $384,000 | -26.4% | 1,261 | -35.2% | 0.00% | -40.0% |
Q2 2021 | $522,000 | +64.2% | 1,947 | +38.0% | 0.01% | +25.0% |
Q1 2021 | $318,000 | -67.3% | 1,411 | -67.8% | 0.00% | -55.6% |
Q4 2020 | $973,000 | -77.9% | 4,382 | -89.2% | 0.01% | -94.3% |
Q3 2018 | $4,411,000 | +27.2% | 40,593 | +15.5% | 0.16% | -25.5% |
Q2 2018 | $3,467,000 | +45.0% | 35,133 | +43.8% | 0.21% | +19.1% |
Q1 2018 | $2,391,000 | +81.4% | 24,424 | +72.0% | 0.18% | +45.9% |
Q4 2017 | $1,318,000 | -28.9% | 14,196 | -34.3% | 0.12% | -18.1% |
Q3 2017 | $1,853,000 | +324.0% | 21,601 | +317.5% | 0.15% | +254.8% |
Q2 2017 | $437,000 | -71.9% | 5,174 | -71.5% | 0.04% | -71.0% |
Q1 2017 | $1,554,000 | +117.6% | 18,170 | +99.6% | 0.14% | +88.3% |
Q3 2016 | $714,000 | +240.0% | 9,102 | +338.7% | 0.08% | +185.2% |
Q2 2016 | $210,000 | -72.8% | 2,075 | -75.0% | 0.03% | -81.6% |
Q4 2015 | $771,000 | +80.6% | 8,298 | +65.6% | 0.15% | +32.4% |
Q3 2015 | $427,000 | +108.3% | 5,012 | +108.0% | 0.11% | +362.5% |
Q1 2015 | $205,000 | -34.1% | 2,410 | -41.1% | 0.02% | -45.5% |
Q3 2014 | $311,000 | +23.9% | 4,092 | +28.5% | 0.04% | +63.0% |
Q2 2014 | $251,000 | -27.5% | 3,184 | -30.9% | 0.03% | -49.1% |
Q1 2014 | $346,000 | -44.2% | 4,609 | -42.6% | 0.05% | -51.8% |
Q4 2013 | $620,000 | – | 8,033 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |